An open-label, randomized comparative pilot study of a single-class quadruple therapy regimen versus a 2-class triple therapy regimen for individuals initiating antiretroviral therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/16518962

Download in:

View as

General Info

PMID
16518962